Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284964386> ?p ?o ?g. }
- W4284964386 endingPage "e0268451" @default.
- W4284964386 startingPage "e0268451" @default.
- W4284964386 abstract "Metformin is a traditional anti-hyperglycemic medication that has recently been shown to benefit vascular complications of diabetes via an anti-inflammatory mechanism other than glycemic control. This study aims to test the hypothesis that metformin suppresses diabetic retinopathy (DR) associated intraocular inflammation. Human vitreous from control and proliferative diabetic retinopathy (PDR) patients with or without long-term metformin treatment (> 5 years) were collected for multiple inflammatory cytokines measurements with a cytokine array kit. The vast majority of the measurable cytokines in PDR vitreous has a lower level in metformin group than non-metformin group. Although the p values are not significant due to a relatively small sample size and large deviations, the 95% confidence interval (CI) for the mean difference between the two groups shows some difference in the true values should not be neglected. Using quantitative ELISA, soluble intercellular adhesion molecule -1 (ICAM-1) and monocyte chemoattractant protein -1 (MCP-1) presented with significantly lower concentrations in metformin group versus non-metformin group. Metformin group also has significantly less up-regulated cytokines and diminished positive correlations among the cytokines when compared to non-metformin group. Possible role of AMP-activated protein kinase (AMPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in metformin's anti-inflammatory effects were studied in human retinal vascular endothelial cells (hRVECs) cultured in normal glucose (NG) and high glucose (HG) conditions. Metformin inhibited HG-induced ICAM-1, IL-8, and MCP-1 via AMPK activation, whereas pharmacological AMPK inhibition had no effect on its inhibition of NF-κB p65, sICAM-1, and tumor necrosis factor-α (TNF-α). Metformin-induced suppression of the inflammatory cytokines could also be mediated through its direct inhibition of NF-κB, independent of AMPK pathway. This is a proof-of-concept study that found metformin treatment was associated with reduced inflammatory responses in vitreous of diabetes patients and retinal vascular endothelial cells, supporting the rationale for using metformin to treat DR at an early stage." @default.
- W4284964386 created "2022-07-10" @default.
- W4284964386 creator A5000124067 @default.
- W4284964386 creator A5015391145 @default.
- W4284964386 creator A5017658620 @default.
- W4284964386 creator A5033963018 @default.
- W4284964386 creator A5034653448 @default.
- W4284964386 creator A5056084219 @default.
- W4284964386 creator A5065869973 @default.
- W4284964386 creator A5076221593 @default.
- W4284964386 creator A5079975369 @default.
- W4284964386 creator A5086704125 @default.
- W4284964386 date "2022-07-08" @default.
- W4284964386 modified "2023-10-01" @default.
- W4284964386 title "Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium" @default.
- W4284964386 cites W1491225188 @default.
- W4284964386 cites W1518103124 @default.
- W4284964386 cites W15447132 @default.
- W4284964386 cites W1574813722 @default.
- W4284964386 cites W1891939305 @default.
- W4284964386 cites W1986398399 @default.
- W4284964386 cites W1986827231 @default.
- W4284964386 cites W1988416361 @default.
- W4284964386 cites W1995897557 @default.
- W4284964386 cites W2016133306 @default.
- W4284964386 cites W2028079896 @default.
- W4284964386 cites W2036984054 @default.
- W4284964386 cites W2039212784 @default.
- W4284964386 cites W2047640394 @default.
- W4284964386 cites W2049871513 @default.
- W4284964386 cites W2064892180 @default.
- W4284964386 cites W2065995883 @default.
- W4284964386 cites W2080654617 @default.
- W4284964386 cites W2087224371 @default.
- W4284964386 cites W2093558293 @default.
- W4284964386 cites W2100262264 @default.
- W4284964386 cites W2102665979 @default.
- W4284964386 cites W2120276758 @default.
- W4284964386 cites W2128188021 @default.
- W4284964386 cites W2138226825 @default.
- W4284964386 cites W2149602039 @default.
- W4284964386 cites W2156424213 @default.
- W4284964386 cites W2157160375 @default.
- W4284964386 cites W2158666727 @default.
- W4284964386 cites W2160546785 @default.
- W4284964386 cites W2166340894 @default.
- W4284964386 cites W2188846692 @default.
- W4284964386 cites W2271771390 @default.
- W4284964386 cites W2336052913 @default.
- W4284964386 cites W2421037982 @default.
- W4284964386 cites W2473725818 @default.
- W4284964386 cites W2610585610 @default.
- W4284964386 cites W2622377758 @default.
- W4284964386 cites W2789680212 @default.
- W4284964386 cites W2793230973 @default.
- W4284964386 cites W2793401320 @default.
- W4284964386 cites W2800640877 @default.
- W4284964386 cites W2893290909 @default.
- W4284964386 cites W2945050649 @default.
- W4284964386 cites W3040209725 @default.
- W4284964386 cites W4211205882 @default.
- W4284964386 cites W4237553878 @default.
- W4284964386 doi "https://doi.org/10.1371/journal.pone.0268451" @default.
- W4284964386 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35802672" @default.
- W4284964386 hasPublicationYear "2022" @default.
- W4284964386 type Work @default.
- W4284964386 citedByCount "12" @default.
- W4284964386 countsByYear W42849643862022 @default.
- W4284964386 countsByYear W42849643862023 @default.
- W4284964386 crossrefType "journal-article" @default.
- W4284964386 hasAuthorship W4284964386A5000124067 @default.
- W4284964386 hasAuthorship W4284964386A5015391145 @default.
- W4284964386 hasAuthorship W4284964386A5017658620 @default.
- W4284964386 hasAuthorship W4284964386A5033963018 @default.
- W4284964386 hasAuthorship W4284964386A5034653448 @default.
- W4284964386 hasAuthorship W4284964386A5056084219 @default.
- W4284964386 hasAuthorship W4284964386A5065869973 @default.
- W4284964386 hasAuthorship W4284964386A5076221593 @default.
- W4284964386 hasAuthorship W4284964386A5079975369 @default.
- W4284964386 hasAuthorship W4284964386A5086704125 @default.
- W4284964386 hasBestOaLocation W42849643861 @default.
- W4284964386 hasConcept C126322002 @default.
- W4284964386 hasConcept C134018914 @default.
- W4284964386 hasConcept C164027704 @default.
- W4284964386 hasConcept C167734588 @default.
- W4284964386 hasConcept C184235292 @default.
- W4284964386 hasConcept C185592680 @default.
- W4284964386 hasConcept C2776780712 @default.
- W4284964386 hasConcept C2776914184 @default.
- W4284964386 hasConcept C2777025900 @default.
- W4284964386 hasConcept C2779829184 @default.
- W4284964386 hasConcept C2780124434 @default.
- W4284964386 hasConcept C2780323712 @default.
- W4284964386 hasConcept C55493867 @default.
- W4284964386 hasConcept C555293320 @default.
- W4284964386 hasConcept C71924100 @default.
- W4284964386 hasConcept C97029542 @default.
- W4284964386 hasConcept C98274493 @default.